Joseph A. Sowell III - Oct 28, 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP; Chief Development Officer
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Oct 28, 2022
Transactions value $: -$2,889,304
Form type: 4
Date filed: 11/1/2022, 06:30 PM
Previous filing: Oct 27, 2022
Next filing: Feb 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Sale	-$2.89M	-12.9K	-100%	$223.18	0	Oct 28, 2022	Direct	F1
holding	HCA	Common Stock						29.8K	Oct 28, 2022	By Trust (Reporting Person and Spouse, Trustees)
holding	HCA	Common Stock						8K	Oct 28, 2022	By Trust (Reporting Person, Trustee)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.00 to $223.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.00 to $223.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.